CN1332678C - Tumour control pill - Google Patents
Tumour control pill Download PDFInfo
- Publication number
- CN1332678C CN1332678C CNB2003101217722A CN200310121772A CN1332678C CN 1332678 C CN1332678 C CN 1332678C CN B2003101217722 A CNB2003101217722 A CN B2003101217722A CN 200310121772 A CN200310121772 A CN 200310121772A CN 1332678 C CN1332678 C CN 1332678C
- Authority
- CN
- China
- Prior art keywords
- cancer
- root
- control pill
- cancer cells
- tumor control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a tumor control pill which is made from three types of traditional Chinese medicines. The tumor control pill overcomes the cancer through perennial research and treatment, has significant curative effect on cancerous patients for early recovering by traditional Chinese medicines, and provides benefits for the cancerous patients. The tumor control pill is economic, is suitable for a plurality of cancerous patients of wage earners to admit, and simultaneously has good effect after the external application of ointment (secret recipe handed down from generation). The tumor control pill can eliminate tumors of mammary cancer, laryngeal cancer, lymphocyte cancer and bone cancer, and alleviate pain. The supporting treatment method can perform the function of external attack. Sal ammoniac has the functions on perforating the tumors of smooth muscle tumors, larynxs, gullets, stomachs, uteruses, bowels, intestines, intestinal walls, etc., killing the cancer cells, causing the cancer cells to be apoptotic, removing the corrosive and rotted meat, promoting the regeneration of tissues, detoxicating and eliminate swelling. Chinese stellera root can reinforce the peristalsis of small bowels and treat the constipation, the experiment mouse has pain threshold of 20 to 50%, and the Chinese stellera root has no side effect on livers, kidneys, digestive functions and hemopoietic systems. Liquoric root with stir-frying has sweet in taste, can proportion bias of various medicaments to well perform the functions, and can be used for invigorating spleens, replenishing qi, moistening lungs for arresting cough, and detoxicating. The Chinese stellera root and the sal ammoniac are combined to use, the drug effect is enhanced, the cancer cells are perforated and killed, the cancer cells are apoptotic, and the liquoric root is simultaneously used for compensating for the defects of the Chinese stellera root and the sal ammoniac. The three types of traditional.
Description
Technical field: the present invention relates to a kind of pharmaceutical composition for the treatment of tumor, belong to the oral Chinese patent medicine technical field.
Background technology: cancer is the life formidable enemy of mankind nowadays, also is a science difficult problem, and is well-known, and the sickness rate of malignant tumor is the trend that rises year by year, and present treatment means mainly is based on operation; Chemotherapy, radiotherapy are auxilliary, and curative effect is not good enough, and mortality rate is in first of all kinds of diseases; Chinese medicine, improving on health immunity and the oncotherapy, no matter be before the operation, should be first-selected after the operation; Cancer patient itself faces the misery of disease, also will bear very big financial burden, is a great pressure to the cancer patient of vast wage-earners, sees that a lot of patients do not have money to go to cure the disease, and my heart is extremely grieved no anti-; In my thought, produce and to cure the disease and to spend less, for the patient reduces the financial burden; Manufacture experimently three flavor medicine preparations under study for action, can cure the disease and can reach target.Take this medicine and only need 2 over thousands of yuan 3 months course of treatment, can delay life, reduce painful numerous cancer patients.
Summary of the invention: inventor Wang Ze invents a kind of pharmaceutical composition for the treatment of tumor in conjunction with the clinical experience for the treatment of the cancer patient for many years, and the present invention forms weight proportion ratio 1: 1: 1 by Sal Ammoniacus, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Glycyrrhizae three flavor medicines;
The Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae): the herbaceous plant of perennation, the root medication, contained Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) glycoside (stellerin) is a kind of antibiotic substance, and its toxicity is very low, contains Saponin, cardiotonic glycoside, sterol, plain trace element analysis found that 27 kinds to Stellera chamaejasme L., wherein zinc, copper, arsenic, cadmium, hydrargyrum etc., but the activity of anticancer growth mainly is the compound monomer of contained two terpene lactone classes.
Toxicity test is observed: Stellera chamaejasme L., water extract are 7.5%-12.5%Kg, and prompting Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) toxicity and side effect are little, Stellera chamaejasme L. strengthens small intestinal peristalsis, can treat constipation, experiment mice threshold of pain 20-50% all has no side effect (showing according to data) to liver, kidney, digestive function and hemopoietic system.
Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) glycoside (stellerin) is to Leuis pulmonary carcinoma, to liver H
22U14, S-180 pulmonary carcinoma suppression ratio are respectively 70.2%-59%, hepatocarcinoma is suppressed 43%-52%, also higher than Herba Crotalariae sessiliflorae, vinblastine, demethyl class hair element to the hepatocarcinoma suppression ratio, thus select for use the Stellera chamaejasme L. element to pulmonary carcinoma, mammary gland, liver, kidney, pancreas, intestinal, cerebral glioma, that the chest glioma suppresses effect is obvious.
Sal Ammoniacus: pharmacology is worn out the tumor-killing cancerous cell to smooth muscle tumor, laryngeal carcinoma, esophagus, stomach, uterus, intestinal, pipe etc., makes cancer cell-apoptosis, and meat is rotted in corrosion removal, granulation promoting detoxifcation, detumescence.Zoopery shows that Sal Ammoniacus has certain inhibitory action, the merit of detumescence to sarcoma S180, watt Ke Shi waker cancer 256 and ascites.
Radix Glycyrrhizae Preparata: sweet in the mouth, process that medication is warm in nature, it can be in harmonious proportion various bias of medicine, play a role better, process with the energy invigorating the spleen and replenishing QI, can control in weakness of the spleen and stomach, the lung moistening and cough, Stellera chamaejasme L. and Sal Ammoniacus share the enhancing drug effect, wear out and kill and wound various cancerous cell, make cancer cell-apoptosis, with the go together deficiency of complementary the first two flavor medicine of Radix Glycyrrhizae, Radix Glycyrrhizae invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, detoxifcation, the synthetic treatment of three flavor medicines cancer can improve body immunity.
The specific embodiment: the present invention relates to a kind of pharmaceutical composition for the treatment of tumor, form weight proportion ratio 1: 1: 1 by Sal Ammoniacus, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Glycyrrhizae three flavor medicines; The processing technology flow process: process of preparing Chinese medicine screening of medicaments-pulverize-mix-be processed into the watered pill-component-packing, with cobalt 60 sterilizations, simultaneously to laryngeal carcinoma, lymph, mammary gland, osteocarcinoma, external application ointment (secret recipe); Effect: tumor disappearance, pain relieving, reach the purpose of healing.
A kind of pharmaceutical composition for the treatment of tumor is made up of Sal Ammoniacus, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Glycyrrhizae three flavor medicines,
Function: antitumor, detumescence, pain relieving.
Cure mainly: liver, lung, brain, larynx, esophagus, stomach, pancreas, uterus, intestinal cancer etc.
Usage: oral 1.2 grams after the every day breakfast, late per os hora somni 1.2 grams.
Points for attention: child, anemia of pregnant woman prohibit clothes.
Claims (1)
1, a kind of pharmaceutical composition for the treatment of tumor, it is characterized in that: the raw material that makes effective ingredient consists of: Sal Ammoniacus, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Glycyrrhizae three flavor medicine weight proportion ratios 1: 1: 1; Method for making: process of preparing Chinese medicine screening of medicaments-pulverize-mix-be processed into the watered pill-component-packing, with cobalt 60 sterilizations, promptly make the oral Chinese patent medicine watered pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101217722A CN1332678C (en) | 2003-12-23 | 2003-12-23 | Tumour control pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101217722A CN1332678C (en) | 2003-12-23 | 2003-12-23 | Tumour control pill |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1554421A CN1554421A (en) | 2004-12-15 |
| CN1332678C true CN1332678C (en) | 2007-08-22 |
Family
ID=34338547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101217722A Expired - Fee Related CN1332678C (en) | 2003-12-23 | 2003-12-23 | Tumour control pill |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1332678C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526176B (en) * | 2012-01-21 | 2013-10-30 | 保定冀中药业有限公司 | Oral administration mineral medicine manufactured by liquorice aqueous extracts |
| CN103948746B (en) * | 2014-04-09 | 2017-11-28 | 中国中医科学院中药研究所 | Application of the Chinese Stellera Root in medicine for anti transfer of tumor is prepared |
-
2003
- 2003-12-23 CN CNB2003101217722A patent/CN1332678C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 中药大辞典 江苏新医学院，570、1900、2083，上海科学技术出版社 1986 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1554421A (en) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102258563B (en) | Anti-cancer medicinal composition and Chinese medicinal composition | |
| CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
| CN102697893A (en) | Application of black raspberry extract (BRBE) in preparation of drugs for treating gastric cancer | |
| CN100593417C (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
| CN102688317B (en) | Traditional Chinese medicine for treating liver cancer | |
| CN101152165A (en) | Antineoplastic isoliquirtigenin tablet | |
| CN108186899A (en) | A kind of Chinese medicine composition for treating tumour and preparation method and application | |
| CN103933450A (en) | Traditional Chinese medicine composition for preventing or/and treating gastrointestinal diseases and preparation method of composition | |
| CN1332678C (en) | Tumour control pill | |
| CN108939043A (en) | A kind of Shark cartilage glycoprotein and its anticancer purpose | |
| CN104367702A (en) | Traditional Chinese medicinal composition for treating tumors | |
| CN102028831B (en) | Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof | |
| CN101129896B (en) | Chinese medicinal herb agentia for treating tumour disease | |
| CN108186921B (en) | An antitumor selenium-containing Chinese medicinal composition and its preparation method | |
| CN101301456A (en) | Compound glaucescent fissistigma root capsule | |
| CN106138697B (en) | Chinese medicinal composition for preventing complications and relieving side effects of radiotherapy and chemotherapy of tumor patients | |
| CN104888128A (en) | Traditional Chinese medicine composition for treatment of cancers | |
| CN118557673B (en) | Traditional Chinese medicine preparation for improving gastrointestinal digestion function and preparation method thereof | |
| CN101391074B (en) | Medicine composition for treating digestive system carcinoma and preparation method thereof | |
| CN109771480B (en) | Traditional Chinese medicine composition for treating livestock and poultry hepatotoxicity and preparation method and preparation thereof | |
| CN106344755B (en) | Compound medicine for treating stomach diseases and preparation method thereof | |
| CN1141139C (en) | Anti-cancer medicine and its preparation method | |
| CN106581572A (en) | Oral medicine for treating breast cancer | |
| CN1352965A (en) | Medicine for treating cancers of esophagus, stomach and lung | |
| CN1313100C (en) | Antitumour Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20041215 Assignee: Heilongjiang Sheng Sheng Chinese Medicine Research Institute Assignor: Wang Ze Contract record no.: 2017230000044 Denomination of invention: Medicine composition for treating tumor Granted publication date: 20070822 License type: Common License Record date: 20170619 |
|
| EE01 | Entry into force of recordation of patent licensing contract | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Ze Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070822 Termination date: 20181223 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |